Form 8-K - Current report:
SEC Accession No. 0001628280-24-024936
Filing Date
2024-05-23
Accepted
2024-05-23 16:11:07
Documents
13
Period of Report
2024-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20240517.htm   iXBRL 8-K 46386
  Complete submission text file 0001628280-24-024936.txt   176088

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20240517.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20240517_lab.xml EX-101.LAB 22994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20240517_pre.xml EX-101.PRE 13115
16 EXTRACTED XBRL INSTANCE DOCUMENT cort-20240517_htm.xml XML 2868
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 24978301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)